
{
  "Company Overview": {
    "Name": "Fonebox Retail Ltd",
    "Sector": "Retail",
    "Industry": "Trading",
    "Business Description": "Fonebox Retail Limited is a multi-brand retailer of smartphones and accessories from brands like Vivo, Apple, Samsung, Oppo, Realme, Nokia, Narzo, Redmi, Motorola, LG, and Micromax.  It operates a retail chain specializing in consumer electronics, with a significant focus on mobile phones, accessories, and related services. The company offers a multi-brand retail experience and aims to deliver high-quality products at competitive rates, encapsulated in its tagline \"Best Brands Best Rates\"",
    "Market Position": "Information not explicitly provided, but peer comparison data is available."
  },
  "Financial Metrics": {
    "Market Cap": "₹ 122 Cr.",
    "Current Price": "₹ 119",
    "High/Low": "₹ 217 / ₹ 116",
    "Stock P/E": "33.9",
    "Book Value": "₹ 30.9",
    "Dividend Yield": "0.00%",
    "ROCE": "41.2%",
    "ROE": "21.3%",
    "Face Value": "₹ 10.0",
    "Debt-to-Equity Ratio": "Information not explicitly provided." 
  },
  "Performance Trends": {
    "Quarterly Results": {
      "Sales": {
        "Mar 2023": "114 Cr",
        "Sep 2023": "140 Cr",
        "Mar 2024": "157 Cr",
        "Sep 2024": "165 Cr"
      },
      "Expenses": {
        "Mar 2023": "111 Cr",
        "Sep 2023": "137 Cr",
        "Mar 2024": "154 Cr",
        "Sep 2024": "162 Cr"
      },
      "Operating Profit": {
        "Mar 2023": "2 Cr",
        "Sep 2023": "3 Cr",
        "Mar 2024": "3 Cr",
        "Sep 2024": "3 Cr"
      },
      "Net Profit": {
        "Mar 2023": "1 Cr",
        "Sep 2023": "2 Cr",
        "Mar 2024": "2 Cr",
        "Sep 2024": "2 Cr"
      },
      "EPS": {
        "Mar 2023": "19.40",
        "Sep 2023": "2.11",
        "Mar 2024": "1.83",
        "Sep 2024": "1.68"
      }
    },
    "Annual Results": {
      "Sales": {
        "Mar 2021": "1 Cr",
        "Mar 2022": "91 Cr",
        "Mar 2023": "196 Cr",
        "Mar 2024": "298 Cr",
        "TTM": "322 Cr"
      },
      "Expenses": {
        "Mar 2021": "1 Cr",
        "Mar 2022": "89 Cr",
        "Mar 2023": "190 Cr",
        "Mar 2024": "288 Cr",
        "TTM": "316 Cr"
      },
      "Operating Profit": {
        "Mar 2021": "-0 Cr",
        "Mar 2022": "2 Cr",
        "Mar 2023": "6 Cr",
        "Mar 2024": "10 Cr",
        "TTM": "6 Cr"
      },
      "Net Profit": {
        "Mar 2021": "-0 Cr",
        "Mar 2022": "0 Cr",
        "Mar 2023": "2 Cr",
        "Mar 2024": "3 Cr",
        "TTM": "4 Cr"
      },
      "EPS": {
        "Mar 2021": "-16.00",
        "Mar 2022": "2.60",
        "Mar 2023": "32.00",
        "Mar 2024": "3.34",
        "TTM": "3.51"
      }
    },
    "Balance Sheet Highlights": {
      "Equity Capital": {
        "Mar 2021": "2 Cr",
        "Mar 2022": "0.50 Cr",
        "Mar 2023": "0.50 Cr",
        "Mar 2024": "10 Cr",
        "Sep 2024": "10 Cr"
      },
      "Total Liabilities": {
        "Mar 2021": "7 Cr",
        "Mar 2022": "22 Cr",
        "Mar 2023": "43 Cr",
        "Mar 2024": "61 Cr",
        "Sep 2024": "69 Cr"
      },
      "Total Assets": {
        "Mar 2021": "7 Cr",
        "Mar 2022": "22 Cr",
        "Mar 2023": "43 Cr",
        "Mar 2024": "61 Cr",
        "Sep 2024": "69 Cr"
      }
    },
    "Cash Flow Summaries": {
      "Cash from Operating Activity": {
        "Mar 2021": "0 Cr",
        "Mar 2022": "-1 Cr",
        "Mar 2023": "-2 Cr",
        "Mar 2024": "-0 Cr"
      },
      "Net Cash Flow": {
        "Mar 2021": "0 Cr",
        "Mar 2022": "0 Cr",
        "Mar 2023": "0 Cr",
        "Mar 2024": "13 Cr"
      }
    }
  },
  "Ratios": {
    "Growth Ratios": {
      "Compounded Sales Growth (3 Years)": "570%",
      "Compounded Sales Growth (TTM)": "27%",
      "Compounded Profit Growth (3 Years)": "154%",
      "Compounded Profit Growth (TTM)": "43%"
    },
    "Liquidity Ratios": {
      "Debtor Days": {
        "Mar 2021": "0",
        "Mar 2022": "9",
        "Mar 2023": "6",
        "Mar 2024": "2"
      },
      "Inventory Days": {
        "Mar 2021": "607",
        "Mar 2022": "46",
        "Mar 2023": "47",
        "Mar 2024": "40"
      },
      "Days Payable": {
        "Mar 2021": "1306",
        "Mar 2022": "53",
        "Mar 2023": "36",
        "Mar 2024": "14"
      },
      "Cash Conversion Cycle": {
        "Mar 2021": "-699",
        "Mar 2022": "3",
        "Mar 2023": "17",
        "Mar 2024": "28"
      },
      "Working Capital Days": {
        "Mar 2021": "-557",
        "Mar 2022": "19",
        "Mar 2023": "34",
        "Mar 2024": "36"
      }
    },
    "Profitability Ratios": {
      "ROCE": {
        "Mar 2021": "35%",
        "Mar 2022": "57%",
        "Mar 2023": "41%",
        "Mar 2024": null
      },
      "ROE": {
        "3 Years": "28%",
        "Last Year": "21%"
      },
      "OPM": {
        "Mar 2023": "2%",
        "Sep 2023": "2%",
        "Mar 2024": "2%",
        "Sep 2024": "2%"
      }
    },
    "Valuation Ratios": {
      "P/E": "33.9",
      "Price to Book": "Information not explicitly provided in a readily extractable format."
    }
  },
  "Peer Comparison": {
    "Peers": [
      {"Name": "Trent", "CMP": "6831.55", "P/E": "178.61", "Mar Cap": "242853.04", "Div Yld": "0.05", "NP Qtr": "335.06", "Qtr Profit Var": "46.92", "Sales Qtr": "4156.67", "Qtr Sales Var": "39.37", "ROCE": "23.79"},
      {"Name": "Avenue Super.", "CMP": "3408.30", "P/E": "82.55", "Mar Cap": "221789.35", "Div Yld": "0.00", "NP Qtr": "659.44", "Qtr Profit Var": "5.79", "Sales Qtr": "14444.50", "Qtr Sales Var": "14.42", "ROCE": "19.41"},
      {"Name": "Brainbees Solut.", "CMP": "638.75", "P/E": null, "Mar Cap": "33162.89", "Div Yld": "0.00", "NP Qtr": "-62.86", "Qtr Profit Var": "50.76", "Sales Qtr": "1904.92", "Qtr Sales Var": "26.41", "ROCE": "-4.00"},
      {"Name": "Redtape", "CMP": "855.85", "P/E": "75.10", "Mar Cap": "11828.01", "Div Yld": "0.00", "NP Qtr": "25.07", "Qtr Profit Var": "-9.63", "Sales Qtr": "415.80", "Qtr Sales Var": "28.05", "ROCE": "29.27"},
      {"Name": "Medplus Health", "CMP": "848.05", "P/E": "101.23", "Mar Cap": "10138.20", "Div Yld": "0.00", "NP Qtr": "38.70", "Qtr Profit Var": "166.16", "Sales Qtr": "1576.17", "Qtr Sales Var": "11.90", "ROCE": "6.66"},
      {"Name": "Ethos Ltd", "CMP": "3101.45", "P/E": "83.80", "Mar Cap": "7592.49", "Div Yld": "0.00", "NP Qtr": "21.25", "Qtr Profit Var": "14.31", "Sales Qtr": "297.13", "Qtr Sales Var": "26.32", "ROCE": "14.91"},
      {"Name": "V-Mart Retail", "CMP": "3780.30", "P/E": null, "Mar Cap": "7483.87", "Div Yld": "0.00", "NP Qtr": "-56.51", "Qtr Profit Var": "11.87", "Sales Qtr": "660.97", "Qtr Sales Var": "20.30", "ROCE": "0.54"}
    ],
    "Median": {
      "CMP": "229.9",
      "P/E": "56.92",
      "Mar Cap": "1343.11",
      "Div Yld": "0.0",
      "NP Qtr": "3.29",
      "Qtr Profit Var": "13.09",
      "Sales Qtr": "328.59",
      "Qtr Sales Var": "17.72",
      "ROCE": "13.52"
    }
  },
  "Other Insights": {
    "Pros": [
      "Company has reduced debt.",
      "Company is almost debt free.",
      "Company has a good return on equity (ROE) track record: 3 Years ROE 28.0%"
    ],
    "Cons": [
      "Though the company is reporting repeated profits, it is not paying out dividend"
    ],
    "Disclaimer": "The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.",
    "Shareholding Pattern": {
      "Promoters": "71.64%",
      "FIIs": "8.79%",
      "DIIs": "0.16%",
      "Public": "19.42%"
    },
    "Notes on Shareholding Data": "* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards. Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes."
  },
  "Documents": [
    {"Title": "Reply to Clarification- Financial results", "Date": "17 December 2024"},
    {"Title": "Clarification - Financial Results", "Date": "9 December 2024"},
    {"Title": "Analysts/Institutional Investor Meet/Con. Call Updates", "Date": "2 December 2024"},
    {"Title": "Analysts/Institutional Investor Meet/Con. Call Updates", "Date": "28 November 2024"},
    {"Title": "Investor Presentation", "Date": "26 November 2024"},
    {"Title": "Annual reports Financial Year 2024", "Source": "nse"}
  ]
}
